Neurogenic Orthostatic Hypotension: Treatments
Treatment of Neurogenic Orthostatic Hypotension
Cardiovascular Disease
Thromboembolic Disorders: Treatments
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Hypertension Evaluation
Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.
AHA Statement on Managing Pregnant Women With CVD
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Hypertension: Beta-Blocker Pharmacokinetics
Beta-blocker pharmacokinetics comparison chart for hypertension.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
FDA Issues Statement Regarding NSAID Use and COVID-19
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
ACC Issues COVID-19 Clinical Guidance for Cardiovascular Care Team
On March 6, 2020, the American College of Cardiology issued COVID-19 clinical guidance for the cardiovascular care team.
Hypertension Treatments: Oral CCBs
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Effect of HCV Clearance on Cardiovascular Risks in People With HIV
In patients coinfected with HIV and HCV, eradication of HCV had no effect on markers of preclinical atherosclerosis and biomarkers of inflammation and endothelial dysfunction.
-
Loading...
-
Loading...
Next post in General Cardiology
